A GM-CSF and CD40L bystander vaccine is effective in a murine breast cancer model
Hatem Soliman,1 Melanie Mediavilla-Varela,2 Scott J Antonia,3 1Department of Women's Oncology and Experimental Therapeutics, 2Department of Immunology, 3Department of Thoracic Oncology, Moffitt Cancer Center, Tampa, FL, USA Background: There is increasing interest in using cancer vaccines t...
Enregistré dans:
Auteurs principaux: | Soliman H, Mediavilla-Varela M, Antonia SJ |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2015
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/e50d07be5b5e4be5a7ca43898ee64387 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Targeting Innate Immunity in Breast Cancer Therapy: A Narrative Review
par: Yanqi Ye, et autres
Publié: (2021) -
Cancer Vaccines and Immunotherapy for Tumor Prevention and Treatment
par: Jagmohan Singh, et autres
Publié: (2021) -
Immunotherapy for HER2-positive breast cancer: recent advances and combination therapeutic approaches
par: Ayoub NM, et autres
Publié: (2019) -
TAPCells, the Chilean dendritic cell vaccine against melanoma and prostate cancer
par: Salazar-Onfray,Flavio, et autres
Publié: (2013) -
Commensal <i>Bifidobacterium</i> Strains Enhance the Efficacy of Neo-Epitope Based Cancer Vaccines
par: Michele Tomasi, et autres
Publié: (2021)